What are you searching for?

Sign in
Company News

FDA Provides Outcome of 5th ICCR Meeting

New working group to be formed related to nanotechnology.

Author Image

By: TOM BRANNA

Editor

The International Cooperation on Cosmetics Regulation (ICCR)— international group of cosmetic regulatory authorities from Canada, the EU Japan, and the US—held its fifth annual meeting (ICCR-5) June 28 -July 1, 2011 in Paris to discuss issues related to cosmetics and cosmetic-like drug/quasi-drug products.

As part of this meeting, the regulators entered into a dialogue with cosmetics industry trade associations from each region, and other interested parties. The meeting focused on the following topics:


•Alternative Test Methods
•Nanotechnologies
•Safety Assessment Principles
•Trace Contaminants
•Involvement of Interested Parties in ICCR

On June 30, the ICCR Regulators hosted an open stakeholder meeting. Participants in this session included members of consumer organizations, industry associations, and academia, with an interest in regulatory issues involving cosmetics. Information on the ICCR process, as well as current work items such as nanotechnology, alternatives to animal testing, trace contaminants and safety of cosmetics was shared.

Several proposals for new work items were presented for future consideration. There are plans to have a similar session at ICCR-6, according to FDA.

In regard to alternative test methods, tegulators received an update from International Cooperation on Alternative Test Methods (ICATM).The report Applicability of Animal Testing Alternatives in Regulatory Frameworks within ICCR Regions was accepted.

Regarding nanotechnology, regulators accepted the report of the ICCR Ad Hoc Working Group on Characterization of Nanomaterials which describes the characterization methods listed in the annex to the Report of the ICCR Joint Ad Hoc Working Group on Nanotechnology in Cosmetic Products:Criteria and Methods of Detection – ICCR-4.

Accoridng to FDA’s update, a new Working Group will be formed to examine methods to characterize insolubility, biopersistance, measurement of size in the realm of 1 to 100 nm in final formulations.

Regulators and industry received an update on the progress of the Ad Hoc Working Group on Safety Assessment of Nanomaterials.
Industry presented the results of a 2011 Associations Survey of Nanomaterials Used in Cosmetics prepared for ICCR.

The ICCR Ad Hoc Traces Working Group provided a report on Principles for Handling Trace materials was accepted. According to the FDA report, discussions continue for recommendations on maximum lead contamination levels and work has already begun on a new document regarding maximum levels of 1,4-dioxane.

ICCR-6 will be held in the US in 2012.

More info: www.fda.gov/Cosmetics

Keep Up With Our Content. Subscribe To Happi Newsletters